DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. scores highest on Nitro (72) and lowest on Price (6). Its PosiPenta is 45.76 out of 100, around the middle of similar companies.
On the Penta Grid this week, DiaMedica Therapeutics Inc. is Grid #369 of 837 in the Healthcare sector in United States, and Grid #2,343 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc. | 45.76 | 6 | 37 | 72 | 52 | 62 |
| Cerus Corporation | 46.44 | 11 | 74 | 64 | 43 | 40 |
| Ovid Therapeutics Inc. | 52.31 | 29 | 40 | 71 | 60 | 62 |
| 908 Devices Inc. | 56.82 | 18 | 58 | 86 | 63 | 58 |
| MapLight Therapeutics, Inc. | 40.66 | 37 | 33 | 16 | 52 | 65 |
| NRC Health | 62.65 | 7 | 86 | 86 | 49 | 85 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -10.51 |
| P/B ratio | 10.65 |
EEarnings
| Trailing EPS | ₹-68.19 |
| Forward EPS | ₹-76.53 |
NNitro
| Price | 716.99 |
| 52-week high | 986.88 |
| 52-week low | 496.78 |
| Fall from 52-week high | 27.3% |
TTorque
| Return on equity (ROE) | -114.61% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.91 |
| Market cap | ₹3,866 Cr |
| Insider holding | 27.83% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is DiaMedica Therapeutics Inc.'s PosiPenta score?
DiaMedica Therapeutics Inc.'s PosiPenta is 45.76 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does DiaMedica Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, DiaMedica Therapeutics Inc. is Grid #369 of 837 in the Healthcare sector in United States, and Grid #2,343 of 4,000 in United States.
Which PosiPenta pillar is strongest for DiaMedica Therapeutics Inc.?
Nitro (momentum), with a score of 72 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for DiaMedica Therapeutics Inc.?
Price (valuation), with a score of 6 out of 100: much weaker than most similar companies.
Has DiaMedica Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 3.13 points, from 42.63 to 45.76.
PositoAI is for research and education only and is not investment advice.